Search for Clinical Trial Results
Neovascularization, Pathologic - 25 Studies Found
Status | Study |
Completed |
Study Name: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial Condition: Choroidal Neovascularization Date: 2006-08-09 Interventions:
|
Completed |
Study Name: Bevacizumab for the Treatment of Corneal Neovascularization Condition: Corneal Neovascularization Date: 2009-10-08 Interventions: Drug: Bevacizumab Topical 10 mg/cc or subconjunctival 2.5 mg/0.1cc |
Recruiting |
Study Name: 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis Condition: Pathological Angiogenesis Date: 2016-01-24 Interventions:
|
Completed |
Study Name: The Effect of Bevacizumab on Corneal Neovascularization Condition: Corneal Neovascularization Date: 2008-11-22 Interventions: Drug: Bevacizumab subconjunctival injection of 1.25 mg bevacizumab and had a follow-up of at least 2 mon |
Completed |
Study Name: Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery Condition: Corneal Neovascularization Date: 2008-10-07 Interventions: Drug: Ranibizumab 0.5mg subconjunctival dose of ranibizumab 3 days prior to corneal transplantation and |
Completed |
Study Name: Treatment of Corneal Neovascularization With Topical Pazopanib Condition: Corneal Neovascularization Date: 2010-11-22 Interventions: Drug: Pazopanib (5mg/ml) Topical pazopanib, 4 times per day for 3 weeks |
Completed |
Study Name: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization Condition: Corneal Neovascularization Date: 2007-11-07 Interventions: Drug: Bevacizumab (Avastin) One dose of 0.1cc of subconjunctival Bevacizumab was applied |
Terminated |
Study Name: Topical IL-1-Ra for Treatment of Corneal Neovascularization Condition: Corneal Neovascularization Date: 2009-06-04 Interventions:
|
Not yet recruiting |
Study Name: Strategies for Management of Corneal Neovascularisation Condition: Corneal Neovascularisation Date: 2015-10-27 Interventions:
|
Completed |
Study Name: Topical Avastin for Treatment of Corneal Neovascularization Condition: Corneal Neovascularization Date: 2007-11-14 Interventions: Drug: Topical Avastin 1% Avastin (bevacizumab) 1% Ot |